RIOK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.952200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.853000E-01
Normal-vs-Stage2
5.073600E-01
Normal-vs-Stage3
2.189800E-01
Normal-vs-Stage4
5.586000E-02
Stage1-vs-Stage2
3.730400E-01
Stage1-vs-Stage3
2.571000E-01
Stage1-vs-Stage4
6.434500E-02
Stage2-vs-Stage3
4.717000E-01
Stage2-vs-Stage4
1.340290E-03
Stage3-vs-Stage4
3.577400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.241800E-01
Normal-vs-AfricanAmerican
8.529000E-01
Normal-vs-Asian
8.417800E-02
Caucasian-vs-AfricanAmerican
3.129600E-01
Caucasian-vs-Asian
9.407800E-02
AfricanAmerican-vs-Asian
3.892300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.157000E-01
Normal-vs-Female
7.143000E-01
Male-vs-Female
3.133200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.298600E-01
Normal-vs-Age(41-60Yrs)
6.659200E-01
Normal-vs-Age(61-80Yrs)
5.770200E-01
Normal-vs-Age(81-100Yrs)
7.006000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.237600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.751400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.245800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.300800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.838600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.713600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.817400E-01
Normal-vs-Daily Drinker
1.313020E-01
Normal-vs-Weekly Drinker
8.659200E-01
Normal-vs-Occasional Drinker
7.264400E-01
Normal-vs-Social Drinker
5.962200E-01
Non Drinker-vs-Daily Drinker
4.701400E-01
Non Drinker-vs-Weekly Drinker
2.369400E-01
Non Drinker-vs-Occasional Drinker
2.712200E-01
Non Drinker-vs-Social Drinker
4.429200E-01
Daily Drinker-vs-Weekly Drinker
6.691600E-02
Daily Drinker-vs-Occasional Drinker
6.172100E-02
Daily Drinker-vs-Social Drinker
1.239370E-01
Weekly Drinker-vs-Occasional Drinker
8.230600E-01
Weekly Drinker-vs-Social Drinker
6.498600E-01
Occasional Drinker-vs-Social Drinker
7.790000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.929800E-01
Normal-vs-Grade 2
7.724400E-01
Normal-vs-Grade 3
8.156600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.562600E-01
Grade 1-vs-Grade 3
6.386400E-01
Grade 1-vs-Grade 4
4.929800E-01
Grade 2-vs-Grade 3
4.747600E-01
Grade 2-vs-Grade 4
7.724400E-01
Grade 3-vs-Grade 4
8.156600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.527400E-01
Normal-vs-NonDiabetic
3.919400E-01
Diabetic-vs-NonDiabetic
6.450000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.470240E-01
Normal-vs-NoPancreatitis
5.070000E-01
Pancreatitis-vs-NoPancreatitis
2.910400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.826600E-01
Normal-vs-N1
5.444000E-01
N0-vs-N1
2.841400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.505800E-01
Normal-vs-TP53-NonMutant
7.823800E-01
TP53-Mutant-vs-TP53-NonMutant
1.823190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
